Shabana Mohammad Ali, “Safety of Dapagliflozinin Reducing Cardiac Events and Deaths among NYHA Class II and III Cardiac Failure Patients”., Pakistan Journal of Medical & Health Sciences, vol. 18, no. 01, p. 35, Apr. 2024.